129 related articles for article (PubMed ID: 31655804)
21. Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats.
Hamano H; Yoshinaga K; Tanaka T; Eta R; Horii T; Kawabata Y; Furuta S; Takei M
Life Sci; 2009 Nov; 85(21-22):759-64. PubMed ID: 19846043
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effect of polaprezinc on cardiac function post-myocardial infarction: A prospective and randomized clinical trial.
Yoshikawa F; Nakajima T; Hanada M; Hirata K; Masuyama T; Aikawa R
Medicine (Baltimore); 2019 Mar; 98(10):e14637. PubMed ID: 30855449
[TBL] [Abstract][Full Text] [Related]
23. Effect of polaprezinc on taste disorders in zinc-deficient rats.
Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M
Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379
[TBL] [Abstract][Full Text] [Related]
24. Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc.
Inaba T; Ishikawa S; Toyokawa T; Ishikawa H; Miyahara K; Wato M; Kawai K; Okada H; Yamamoto K
Hepatogastroenterology; 2010; 57(99-100):678-84. PubMed ID: 20698249
[TBL] [Abstract][Full Text] [Related]
25. [A Case of Transverse Colon Cancer with Liver Metastasis and Tumor Thrombosis of Portal Vein Effectively Treated with Chemotherapy].
Aida T; Shiobara M; Wakatsuki K; Arai S; Suda K; Miyazawa K; Miyoshi T; Takahashi Y; Yoshioka S
Gan To Kagaku Ryoho; 2018 Feb; 45(2):374-376. PubMed ID: 29483452
[TBL] [Abstract][Full Text] [Related]
26. Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy.
Hayashi H; Kobayashi R; Suzuki A; Yamada Y; Ishida M; Shakui T; Kitagawa J; Hayashi H; Sugiyama T; Takeuchi H; Tsurumi H; Itoh Y
Med Oncol; 2016 Aug; 33(8):91. PubMed ID: 27418192
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
Funato M; Ozeki M; Suzuki A; Ishihara M; Kobayashi R; Nozawa A; Yasue S; Endo-Ohnishi S; Fukao T; Itoh Y
Anticancer Res; 2018 Aug; 38(8):4691-4697. PubMed ID: 30061237
[TBL] [Abstract][Full Text] [Related]
28. [Preventive effect of polaprezinc suspension dispersed in sodium alginate solution (P-AG) for stomatitis induced by Docetaxel/Cisplatin/Fluorouracil (DCF) chemotherapy in patients with head and neck cancer].
Sugisaki T; Kawakami K; Nemoto M; Kawata K; Ishibashi M; Fujiki Y; Mishima Y; Yokoyama M; Takahashi S; Hatake K; Hama T
Gan To Kagaku Ryoho; 2011 May; 38(5):783-7. PubMed ID: 21566437
[TBL] [Abstract][Full Text] [Related]
29. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate.
Kato S; Nishiwaki H; Konaka A; Takeuchi K
Dig Dis Sci; 1997 Oct; 42(10):2156-63. PubMed ID: 9365151
[TBL] [Abstract][Full Text] [Related]
30. Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.
Hayashi H; Kobayashi R; Suzuki A; Ishihara M; Nakamura N; Kitagawa J; Kanemura N; Kasahara S; Kitaichi K; Hara T; Tsurumi H; Moriwaki H; Itoh Y
Anticancer Res; 2014 Dec; 34(12):7271-7. PubMed ID: 25503160
[TBL] [Abstract][Full Text] [Related]
31. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
[TBL] [Abstract][Full Text] [Related]
32. Polaprezinc attenuates Helicobacter pylori-associated gastritis in Mongolian gerbils.
Ishihara R; Iishi H; Sakai N; Yano H; Uedo N; Narahara H; Iseki K; Mikuni T; Ishiguro S; Tatsuta M
Helicobacter; 2002 Dec; 7(6):384-9. PubMed ID: 12485126
[TBL] [Abstract][Full Text] [Related]
33. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice.
Ohkawara T; Takeda H; Kato K; Miyashita K; Kato M; Iwanaga T; Asaka M
Scand J Gastroenterol; 2005 Nov; 40(11):1321-7. PubMed ID: 16334442
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of polaprezinc for acute radiation proctitis in a rat model.
Doi H; Kamikonya N; Takada Y; Fujiwara M; Tsuboi K; Inoue H; Tanooka M; Nakamura T; Shikata T; Tsujimura T; Hirota S
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):877-84. PubMed ID: 21377290
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Himoto T; Hosomi N; Nakai S; Deguchi A; Kinekawa F; Matsuki M; Yachida M; Masaki T; Kurokochi K; Watanabe S; Senda S; Kuriyama S
Scand J Gastroenterol; 2007 Sep; 42(9):1078-87. PubMed ID: 17710674
[TBL] [Abstract][Full Text] [Related]
36. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection.
Kashimura H; Suzuki K; Hassan M; Ikezawa K; Sawahata T; Watanabe T; Nakahara A; Mutoh H; Tanaka N
Aliment Pharmacol Ther; 1999 Apr; 13(4):483-7. PubMed ID: 10215732
[TBL] [Abstract][Full Text] [Related]
37. Disposition of polaprezinc (zinc L-carnosine complex) in rat gastrointestinal tract and effect of cimetidine on its adhesion to gastric tissues.
Furuta S; Toyama S; Miwa M; Sano H
J Pharm Pharmacol; 1995 Aug; 47(8):632-6. PubMed ID: 8583362
[TBL] [Abstract][Full Text] [Related]
38. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
[TBL] [Abstract][Full Text] [Related]
39. Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review.
Doi H; Kuribayashi K; Kijima T
Future Oncol; 2018 Aug; 14(19):1977-1988. PubMed ID: 30074413
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of polaprezinc on the inflammatory response to Helicobacter pylori.
Handa O; Yoshida N; Tanaka Y; Ueda M; Ishikawa T; Takagi T; Matsumoto N; Naito Y; Yoshikawa T
Can J Gastroenterol; 2002 Nov; 16(11):785-9. PubMed ID: 12464972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
